| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |